Myasthenia gravis
Conditions
Interventions
Observation groups (stratified by: glucocorticoids alone
glucocorticoids + conventional oral immunosuppressants
glucocorticoids + efgartigimod
glucocorticoids + conventional oral immunosuppressants + efgartigimod):None
Sponsors
West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Male or female patients older than 18 years; 2.The patient met the diagnostic criteria of MG in the Chinese Guidelines for the Diagnosis and treatment of Myasthenia gravis (2020 edition); 3.During the maintenance period, patients were regularly treated with glucocorticoid alone, glucocorticoid + traditional oral immunosuppressant, glucocorticoid + igatimod, and glucocorticoid + traditional oral immunosuppressant + igatimod for up to 1 year.
Exclusion criteria
Exclusion criteria: 1.Patients with severe mental disorders were unable to cooperate with follow-up; 2.Compliance was low;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Questionnaires and scales (including MG Composite score, MG-ADL score, etc.); | — |
Secondary
| Measure | Time frame |
|---|---|
| Baseline and clinical history data (including age, gender, results of myasthenia gravis antibody tests, medication regimen, and comorbidities); | — |
Countries
China
Contacts
Public ContactZhou Hongyu
West China Hospital of Sichuan University
Outcome results
None listed